Clinical trial
MicroSpA & MicroRA: The Role of Microbiome on Biological Therapy Efficacy in Axial Spondyloarthritis and Rheumatoid Arthritis - a New Paradigm
NCT04973787 is registered in ClinicalTrials.gov with Universidade Nova de Lisboa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MicroSpA & MicroRA: The Role of Microbiome on Biological Therapy Efficacy in Axial Spondyloarthritis and Rheumatoid Arthritis - a New Paradigm
- Lead sponsor
- Universidade Nova de Lisboa
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 1, 2020
- Completion date
- January 31, 2022
- Enrollment
- 90 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.